Recombinant rhIGF-I/rhIGFBP-3 investigated for improving endurance, cognition, and muscle function in Myotonic Dystrophy Type 1.
Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
Abstract
A 24-week study investigated rhIGF-I/rhIGFBP-3 for improving endurance, ambulation, cognition, and metabolic parameters in Myotonic Dystrophy Type 1 patients.